Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

T Monschein; S Dekany; T Zrzavy; M Ponleitner; P Altmann; G Bsteh; B Kornek; P Rommer; C Enzinger; F Di Pauli; Jörg Kraus; T Berger; F Leutmezer; M Guger; null Austrian MS Treatment Registry AMSTR

doi:10.1007/s00415-023-11784-1

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

T Monschein, S Dekany, T Zrzavy, M Ponleitner, P Altmann, G Bsteh, B Kornek, P Rommer, C Enzinger, F Di Pauli, Jörg Kraus (Co-author), T Berger, F Leutmezer, M Guger, Austrian MS Treatment Registry AMSTR

Department of Labratory Medicine

Research output: Contribution to journal › Correction › peer-review

Original language	English
Pages (from-to)	3787
Journal	JOURNAL OF NEUROLOGY
Volume	270
Issue number	8
DOIs	https://doi.org/10.1007/s00415-023-11784-1
Publication status	Published - Aug 2023

Access to Document

10.1007/s00415-023-11784-1

1 Original Article

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
Monschein, T., Dekany, S., Zrzavy, T., Ponleitner, M., Altmann, P., Bsteh, G., Kornek, B., Rommer, P., Enzinger, C., Di Pauli, F., Kraus, J. (Co-author), Berger, T., Leutmezer, F. & Guger, M., 2023, In: JOURNAL OF NEUROLOGY .
Research output: Contribution to journal › Original Article › peer-review

2 Citations (Web of Science)

Cite this

Monschein, T., Dekany, S., Zrzavy, T., Ponleitner, M., Altmann, P., Bsteh, G., Kornek, B., Rommer, P., Enzinger, C., Di Pauli, F., Kraus, J., Berger, T., Leutmezer, F., Guger, M., & Austrian MS Treatment Registry AMSTR (2023). Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). JOURNAL OF NEUROLOGY , 270(8), 3787. https://doi.org/10.1007/s00415-023-11784-1

Monschein, T ; Dekany, S ; Zrzavy, T et al. / Correction : Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). In: JOURNAL OF NEUROLOGY 2023 ; Vol. 270, No. 8. pp. 3787.

@article{49269d8664b6455487b865e98af73473,

title = "Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)",

author = "T Monschein and S Dekany and T Zrzavy and M Ponleitner and P Altmann and G Bsteh and B Kornek and P Rommer and C Enzinger and {Di Pauli}, F and J{\"o}rg Kraus and T Berger and F Leutmezer and M Guger and {Austrian MS Treatment Registry AMSTR}",

note = "Kraus: Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria",

year = "2023",

month = aug,

doi = "10.1007/s00415-023-11784-1",

language = "English",

volume = "270",

pages = "3787",

journal = "JOURNAL OF NEUROLOGY ",

issn = "0340-5354",

publisher = "Springer Nature",

number = "8",

}

Monschein, T, Dekany, S, Zrzavy, T, Ponleitner, M, Altmann, P, Bsteh, G, Kornek, B, Rommer, P, Enzinger, C, Di Pauli, F, Kraus, J, Berger, T, Leutmezer, F, Guger, M & Austrian MS Treatment Registry AMSTR 2023, 'Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)', JOURNAL OF NEUROLOGY , vol. 270, no. 8, pp. 3787. https://doi.org/10.1007/s00415-023-11784-1

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). / Monschein, T; Dekany, S; Zrzavy, T et al.
In: JOURNAL OF NEUROLOGY , Vol. 270, No. 8, 08.2023, p. 3787.

Research output: Contribution to journal › Correction › peer-review

TY - JOUR

T1 - Correction

T2 - Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

AU - Monschein, T

AU - Dekany, S

AU - Zrzavy, T

AU - Ponleitner, M

AU - Altmann, P

AU - Bsteh, G

AU - Kornek, B

AU - Rommer, P

AU - Enzinger, C

AU - Di Pauli, F

AU - Kraus, Jörg

AU - Berger, T

AU - Leutmezer, F

AU - Guger, M

AU - Austrian MS Treatment Registry AMSTR, null

N1 - Kraus: Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria

PY - 2023/8

Y1 - 2023/8

U2 - 10.1007/s00415-023-11784-1

DO - 10.1007/s00415-023-11784-1

M3 - Correction

C2 - 37272963

SN - 0340-5354

VL - 270

SP - 3787

JO - JOURNAL OF NEUROLOGY

JF - JOURNAL OF NEUROLOGY

IS - 8

ER -

Monschein T, Dekany S, Zrzavy T, Ponleitner M, Altmann P, Bsteh G et al. Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). JOURNAL OF NEUROLOGY . 2023 Aug;270(8):3787. doi: 10.1007/s00415-023-11784-1